I-tech
50.20 SEK
+5.46 %
Less than 1K followers
ITECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for I-tech
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 40.8 | 57.8 | 179.5 | 56.9 | 31.6 | 41.0 | 38.7 | 168.1 |
| EBITDA | 11.5 | 18.8 | 53.7 | 19.7 | 6.2 | 13.1 | 9.6 | 48.5 |
| EBIT | 9.4 | 16.8 | 45.5 | 17.7 | 4.7 | 11.1 | 7.6 | 41.0 |
| EBIT-% | 23.2 % | 29.0 % | 25.3 % | 31.0 % | 15.0 % | 27.1 % | 19.5 % | 24.4 % |
| Profit before taxes | 9.8 | 18.1 | 49.2 | 17.5 | 4.5 | 11.8 | 8.1 | 41.8 |
| Net income | 7.8 | 14.3 | 39.0 | 13.9 | 3.6 | 9.4 | 6.4 | 33.2 |